The Federal Government has introduced the Electronic Pharmacy Regulations 2026 to regulate Nigeria's expanding digital pharmaceutical market. Unveiled in Abuja on Friday, the framework aims to improve medicine safety, strengthen supply chain controls and combat the circulation of fake drugs. Represented by Dr Abisola Adegoke, the Director of Hospital Services, the Permanent Secretary of the Federal Ministry of Health and Social Welfare, Daju Kachollum, described the regulations as a milestone in healthcare oversight. She stated the framework emerged from collaboration with technology innovators, healthcare providers and legal experts, and is designed to ensure accessibility, security and accountability in online pharmacy operations. Kachollum emphasized that the regulations will enhance medicine traceability, strengthen prescription systems and expand safe access to pharmaceuticals in urban and underserved areas. The Coordinating Minister of Health and Social Welfare, Prof Muhammad Pate, said the move is part of broader reforms to formalize Nigeria's pharmaceutical market. He cited the sector's history of informal, loosely regulated distribution channels, calling the previous system "haphazard" and harmful. Pate stressed the new rules prioritize patient safety, data protection and accountability, with digital tools central to improving health outcomes. Pharmacist Ibrahim Ahmed, Registrar of the Pharmacy Council of Nigeria, noted the rapid growth of digital health platforms during the COVID-19 pandemic, which exposed weaknesses in pharmaceutical supply chains. He said the shift to online platforms had outpaced existing regulations, making the new framework necessary to protect consumers.
Daju Kachollum's presentation of the Electronic Pharmacy Regulations 2026 as a product of multi-stakeholder collaboration stands in contrast to the long-standing inertia in regulating Nigeria's pharmaceutical sector, raising questions about why it took a pandemic to trigger formal oversight of digital drug sales. The fact that the Pharmacy Council of Nigeria only moved decisively after the surge in online platforms during COVID-19 underscores how reactive, rather than proactive, health governance has been.
Prof Muhammad Pate's acknowledgment of a "haphazard" pharmaceutical market confirms what consumers have endured for years: a system where counterfeit drugs thrive due to fragmented oversight and weak enforcement. The new regulations attempt to correct this by mandating compliance through digital traceability and prescription controls, but the real test lies in implementation—especially given past failures to police physical pharmacies. The emphasis on attracting investment suggests the government sees regulatory clarity as a tool for market confidence, not just public health.
Millions of Nigerians who rely on online platforms for medicine access, particularly in areas with few physical pharmacies, may benefit from safer, verified services—if enforcement is consistent. However, those in low-bandwidth rural regions might be left behind if digital infrastructure isn't improved alongside regulation.
This move fits a broader pattern: Nigeria often waits for crises to catalyze reform, from power sector overhauls after blackouts to health regulations post-pandemic. The e-pharmacy rules are not just about drugs—they signal a reluctant but necessary digital maturation of public oversight.
